StockData
Curaleaf Holdings, Inc. logo

Curaleaf Holdings, Inc. (CURLF) stock

CURLFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 6/30
$7.63−0.20 (-2.55%)

Close on Oct 19, 2026Market cap $2.07BP/E –Yield –

Curaleaf ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was $222.06M, down 13.3% from the year before. The highest annual figure on record is $256.20M in fiscal 2024.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$222.06M-13.3%
FY2024Dec 31, 2024$256.20M+7.3%
FY2023Dec 31, 2023$238.76M+8.1%
FY2022Dec 31, 2022$220.97M+23.4%
FY2021Dec 31, 2021$179.12M+17.7%
FY2020Dec 31, 2020$152.15M+1503.4%
FY2019Dec 31, 2019$9.49M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$52.83M–
Q2 FY2025Jun 30, 2025$55.41M–

More Curaleaf figures

See a number that looks wrong?